|
68 Companies |
|
79 Products |
|
79 Products |
|
71 Mechanisms of Action |
|
0 Trials |
|
484 News |
|
| 12345678910» |
- | Trial completion: Evaluation of an Integrated Care Project (clinicaltrials.gov) - Feb 16, 2019
P=N/A, N=3960, Completed, Sponsor: Charite University, Berlin, Germany
Enrolling by invitation --> Completed
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Potential Research Study Participant Registry (clinicaltrials.gov) - Feb 16, 2019
P=N/A, N=265, Completed, Sponsor: University of California, Davis
Enrolling by invitation --> Completed Recruiting --> Completed | N=200 --> 265 | Trial completion date: Jan 2025 --> Sep 2018 | Trial primary completion date: Jan 2025 --> Sep 2018
- | triamcinolone acetonide topical / Generic mfg.
Biomarker, Trial termination, Biopsy: GNE-AD: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (clinicaltrials.gov) - Jan 24, 2019
P4, N=11, Terminated, Sponsor: University of California, San Francisco
Recruiting --> Completed | N=200 --> 265 | Trial completion date: Jan 2025 --> Sep 2018 | Trial primary completion date: Jan 2025 --> Sep 2018 Completed --> Terminated; Unable to meet the study's recruitment goals
- | Trial completion, Trial completion date: Assessing Risk of Food Insecurity Within Households of Children With Food Allergy (clinicaltrials.gov) - Oct 16, 2018
P=N/A, N=650, Completed, Sponsor: Arkansas Children's Hospital Research Institute
Completed --> Terminated; Unable to meet the study's recruitment goals Enrolling by invitation --> Completed | Trial completion date: Dec 2017 --> Aug 2018
- | Phase classification, HEOR, Cost effectiveness: Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis (clinicaltrials.gov) - Sep 12, 2018
P4, N=39, Completed, Sponsor: Wake Forest University Health Sciences
Enrolling by invitation --> Completed | Trial completion date: Dec 2017 --> Aug 2018 Phase classification: P=N/A --> P4
- | Phase classification: Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis (clinicaltrials.gov) - Sep 7, 2018
P2, N=10, Completed, Sponsor: Wake Forest University
Phase classification: P=N/A --> P4 Phase classification: P=N/A --> P2
- | Trial completion, Enrollment change: Immune Reactions in Contact Dermatitis Affected Skin (clinicaltrials.gov) - Jun 20, 2018
P=N/A, N=9, Completed, Sponsor: Rockefeller University
Phase classification: P=N/A --> P2 Enrolling by invitation --> Completed | N=120 --> 9
- ||| Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Enrollment change: Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis (clinicaltrials.gov) - Jun 3, 2018
P2b, N=204, Completed, Sponsor: MedImmune LLC
Enrolling by invitation --> Completed | N=120 --> 9 N=306 --> 204
- | tacrolimus topical / Generic mfg.
Trial completion, Enrollment change, Trial completion date: Tacrolimus Ointment Interest (PROTOPIC (clinicaltrials.gov) - Jun 1, 2018
P3, N=120, Completed, Sponsor: University Hospital, Rouen
N=306 --> 204 Recruiting --> Completed | N=240 --> 120 | Trial completion date: Jun 2018 --> Oct 2017
- |||| timapiprant (OC000459) / Chiesi
Trial completion: Effect of OC000459 on Moderate to Severe Atopic Dermatitis (clinicaltrials.gov) - Mar 26, 2018
P2, N=142, Completed, Sponsor: Atopix Therapeutics, Ltd.
Recruiting --> Completed | N=240 --> 120 | Trial completion date: Jun 2018 --> Oct 2017 Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial completion date, Trial primary completion date: Registry for the Atopic Dermatitis Research Network (clinicaltrials.gov) - Mar 2, 2018
P=N/A, N=3386, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Recruiting --> Completed | N=2600 --> 3386 | Trial primary completion date: Feb 2020 --> Feb 2018 | Trial completion date: Feb 2020 --> Feb 2018
- | Reimbursement, Trial primary completion date: Evaluation of an Integrated Care Project (clinicaltrials.gov) - Jan 30, 2018
P=N/A, N=3960, Enrolling by invitation, Sponsor: Charite University, Berlin, Germany
Recruiting --> Completed | N=2600 --> 3386 | Trial primary completion date: Feb 2020 --> Feb 2018 | Trial completion date: Feb 2020 --> Feb 2018 Trial primary completion date: Dec 2017 --> Dec 2018
- | Trial completion: Assessment of Efficacy of the Consumption of a Heat-treated Lactobacillus Paracasei (GM080) on Atopic Dermatitis (clinicaltrials.gov) - Jan 26, 2018
P=N/A, N=126, Completed, Sponsor: Nestlé
Trial primary completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed
- | tacrolimus topical / Generic mfg.
Trial completion, Adherence: Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit (clinicaltrials.gov) - Dec 20, 2017
P4, N=30, Completed, Sponsor: Wake Forest University
Active, not recruiting --> Completed Recruiting --> Completed
- | Stelara (ustekinumab) / J&J
Trial completion, Trial primary completion date: Pilot Study of Ustekinumab for Subjects With Chronic Atopic Dermatitis (clinicaltrials.gov) - Dec 19, 2017
P2, N=32, Completed, Sponsor: Rockefeller University
Recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 | Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 | Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015
- | triamcinolone acetonide topical / Generic mfg.
Enrollment change, Trial withdrawal, Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - Nov 1, 2017
P=N/A, N=0, Withdrawn, Sponsor: Wake Forest University
Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 | Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 | Active, not recruiting --> Completed | Trial primary completion date: Mar 2018 --> Mar 2015 N=40 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Oct 2017 --> Oct 2014
- |||| Dupixent (dupilumab) / Sanofi, Regeneron
Trial primary completion date: CHRONOS: Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis (clinicaltrials.gov) - Oct 17, 2017
P3, N=740, Completed, Sponsor: Regeneron Pharmaceuticals
N=40 --> 0 | Active, not recruiting --> Withdrawn | Trial primary completion date: Oct 2017 --> Oct 2014 Trial primary completion date: Nov 2015 --> Aug 2015
- | Trial completion, Enrollment change: The Head Injury-associated Photosensitivity and Pupillary Function (HIPP) Study (clinicaltrials.gov) - Sep 25, 2017
P=N/A, N=40, Completed, Sponsor: Ohio State University
Trial primary completion date: Nov 2015 --> Aug 2015 Active, not recruiting --> Completed | N=80 --> 40
- | Trial completion, Enrollment change: Bleach Bath Treatment of Adults With Atopic Dermatitis (clinicaltrials.gov) - Jul 13, 2017
P=N/A, N=58, Completed, Sponsor: University of Rochester
Active, not recruiting --> Completed | N=80 --> 40 Recruiting --> Completed | N=30 --> 58
- | Enrollment change: Immune Reactions in Contact Dermatitis Affected Skin (clinicaltrials.gov) - Jun 8, 2017
P=N/A, N=120, Enrolling by invitation, Sponsor: Rockefeller University
Recruiting --> Completed | N=30 --> 58 N=500 --> 120
- | Phase classification: Comparison Between Asynchronous Online Care Model With Usual In Office Care for the Management of Atopic Dermatitis (clinicaltrials.gov) - May 30, 2017
P=N/A, N=183, Completed, Sponsor: University of California, Davis
N=500 --> 120 Phase classification: P2 --> P=N/A
- || Enrollment change: To Evaluate the Safety and Efficacy of a New Device in the Management of Mild to Moderate Atopic Dermatitis in Children (clinicaltrials.gov) - May 23, 2017
P=N/A, N=82, Completed, Sponsor: Johnson & Johnson Consumer and Personal Products Worldwide
Phase classification: P2 --> P=N/A N=108 --> 82
- Trial completion, Trial initiation date, Trial primary completion date: Efficacy of Fluocinonide Cream 0.1% (Vanos(R)) in Reducing Itch in Subjects With Atopic Dermatitis (clinicaltrials.gov) - May 1, 2017
P=N/A, N=10, Completed, Sponsor: Wake Forest University
N=108 --> 82 Recruiting --> Completed | Initiation date: Nov 2011 --> Feb 2012 | Trial primary completion date: Dec 2016 --> Aug 2013
- Trial termination: Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis (clinicaltrials.gov) - Apr 25, 2017
P2, N=13, Terminated, Sponsor: University of Medicine and Dentistry of New Jersey
Recruiting --> Completed | Initiation date: Nov 2011 --> Feb 2012 | Trial primary completion date: Dec 2016 --> Aug 2013 Completed --> Terminated; Low enrollment
- | hydrocortisone butyrate / Generic mfg.
Trial completion, Adherence: Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis (clinicaltrials.gov) - Apr 20, 2017
P4, N=26, Completed, Sponsor: Wake Forest University
Completed --> Terminated; Low enrollment Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date: Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy (clinicaltrials.gov) - Apr 12, 2017
P=N/A, N=400, Completed, Sponsor: Region Skane
Active, not recruiting --> Completed Recruiting --> Completed | N=600 --> 400 | Trial primary completion date: Jan 2017 --> Sep 2016
- | triamcinolone acetonide topical / Generic mfg.
Biomarker, Trial completion, Enrollment change, Trial primary completion date, IO biomarker, Biopsy: GNE-AD: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (clinicaltrials.gov) - Apr 12, 2017
P4, N=11, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed | N=600 --> 400 | Trial primary completion date: Jan 2017 --> Sep 2016 Recruiting --> Completed | N=15 --> 11 | Trial primary completion date: Jan 2017 --> Apr 2017
- | pimecrolimus topical / Generic mfg.
Phase classification, Preclinical, Biopsy: Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis (clinicaltrials.gov) - Mar 29, 2017
P=N/A, N=28, Completed, Sponsor: National Jewish Health
Recruiting --> Completed | N=15 --> 11 | Trial primary completion date: Jan 2017 --> Apr 2017 Phase classification: P4 --> P=N/A
- Enrollment change, Trial termination, Head-to-Head: CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in Infants (clinicaltrials.gov) - Mar 28, 2017
P=N/A, N=3, Terminated, Sponsor: Northwestern University
Phase classification: P4 --> P=N/A N=40 --> 3 | Recruiting --> Terminated; Principal Investigator and sponsor agreed to termination.
- | Trial completion, Enrollment change, Trial primary completion date: Neurobiology of the Scalp in Seborrheic Dermatitis (clinicaltrials.gov) - Mar 27, 2017
P=N/A, N=32, Completed, Sponsor: Boston University
N=40 --> 3 | Recruiting --> Terminated; Principal Investigator and sponsor agreed to termination. Recruiting --> Completed | N=24 --> 32 | Trial primary completion date: Aug 2015 --> May 2014
- | Enrollment change, Trial withdrawal: Study to Examine the Benefits of Fabric Made With Lyocell/Chitosan/Ceramide in the Treatment of Children With Mild to Moderate Eczema (clinicaltrials.gov) - Mar 24, 2017
P=N/A, N=0, Withdrawn, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Recruiting --> Completed | N=24 --> 32 | Trial primary completion date: Aug 2015 --> May 2014 N=60 --> 0 | Not yet recruiting --> Withdrawn
- | Adbry (tralokinumab-ldrm) / LEO Pharma, AstraZeneca
Phase classification: Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis (clinicaltrials.gov) - Mar 21, 2017
P2b, N=306, Completed, Sponsor: MedImmune LLC
N=60 --> 0 | Not yet recruiting --> Withdrawn Phase classification: P2 --> P2b
- | triamcinolone acetonide topical / Generic mfg.
Trial primary completion date, Adherence: Pediatric Atopic Dermatitis (AD) Internet Survey (clinicaltrials.gov) - Mar 13, 2017
P=N/A, N=40, Active, not recruiting, Sponsor: Wake Forest University
Phase classification: P2 --> P2b Trial primary completion date: Oct 2016 --> Oct 2017
- | Reimbursement, Trial primary completion date: Evaluation of an Integrated Care Project (clinicaltrials.gov) - Mar 9, 2017
P=N/A, N=3960, Enrolling by invitation, Sponsor: Charite University, Berlin, Germany
Trial primary completion date: Oct 2016 --> Oct 2017 Trial primary completion date: Nov 2015 --> Dec 2017
- betamethasone/dexchlorpheniramine maleate / Generic mfg., prednisolone / Generic mfg.
Enrollment change, Trial termination, Trial primary completion date: Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment (clinicaltrials.gov) - Feb 16, 2017
P3, N=17, Terminated, Sponsor: EMS
Trial primary completion date: Nov 2015 --> Dec 2017 N=140 --> 17 | Recruiting --> Terminated | Trial primary completion date: Mar 2016 --> Aug 2016; By sponsor decision due to difficulty of recruitment
- ||| AIMab7195 / Nestle
Trial completion, Trial primary completion date: Safety and Tolerability of XmAb (clinicaltrials.gov) - Jan 24, 2017
P1, N=72, Completed, Sponsor: Xencor, Inc.
N=140 --> 17 | Recruiting --> Terminated | Trial primary completion date: Mar 2016 --> Aug 2016; By sponsor decision due to difficulty of recruitment Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Sep 2015
- | SB011 / Sterna Biologicals
Trial completion: Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema (clinicaltrials.gov) - Jan 13, 2017
P2a, N=25, Completed, Sponsor: Sterna Biologicals GmbH & Co. KG
Active, not recruiting --> Completed | Trial primary completion date: Mar 2016 --> Sep 2015 Active, not recruiting --> Completed
- Enrollment open, Enrollment change, Trial primary completion date: Bleach Bath Treatment of Adults With Atopic Dermatitis (clinicaltrials.gov) - Dec 29, 2016
P=N/A, N=30, Recruiting, Sponsor: University of Rochester
Active, not recruiting --> Completed Completed --> Recruiting | N=46 --> 30 | Trial primary completion date: Apr 2016 --> May 2017
- tacrolimus topical / Generic mfg.
Trial primary completion date: Tacrolimus Ointment Interest (PROTOPIC (clinicaltrials.gov) - Dec 7, 2016
P3, N=240, Recruiting, Sponsor: University Hospital, Rouen
Completed --> Recruiting | N=46 --> 30 | Trial primary completion date: Apr 2016 --> May 2017 Trial primary completion date: Dec 2016 --> Dec 2017
- Trial completion, Trial primary completion date: Randomized Controlled Trial of an Eczema Care Plan (clinicaltrials.gov) - Dec 1, 2016
P=N/A, N=211, Completed, Sponsor: Boston Children’s Hospital
Trial primary completion date: Dec 2016 --> Dec 2017 Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Sep 2016
- Enrollment closed: Assessment of Efficacy of the Consumption of a Heat-treated Lactobacillus Paracasei (GM080) on Atopic Dermatitis (clinicaltrials.gov) - Nov 28, 2016
P=N/A, N=126, Active, not recruiting, Sponsor: Nestlé
Recruiting --> Completed | Trial primary completion date: Jun 2016 --> Sep 2016 Recruiting --> Active, not recruiting
- | SB011 / Sterna Biologicals
Enrollment closed, Trial primary completion date: Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of the Topical Formulation SB011 Applied to Lesional Skin in Patients With Atopic Eczema (clinicaltrials.gov) - Nov 8, 2016
P2a, N=26, Active, not recruiting, Sponsor: Sterna Biologicals GmbH & Co. KG
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2016
- ||||||| Dupixent (dupilumab) / Sanofi, Regeneron
Trial completion: CHRONOS: Study to Assess the Efficacy and Long-term Safety of Dupilumab (REGN668/SAR231893) in Adult Participants With Moderate-to-Severe Atopic Dermatitis (clinicaltrials.gov) - Nov 3, 2016
P3, N=739, Completed, Sponsor: Regeneron Pharmaceuticals
Recruiting --> Active, not recruiting | Trial primary completion date: Jul 2015 --> Dec 2016 Active, not recruiting --> Completed
- triamcinolone acetonide topical / Generic mfg.
Biomarker, Trial primary completion date, IO biomarker, Biopsy: GNE-AD: A Study to Determine Serum and Skin Biopsy Biomarkers in Patients Receiving Topical Corticosteroid (TCS) and Following TCS Withdrawal (clinicaltrials.gov) - Oct 27, 2016
P4, N=15, Recruiting, Sponsor: University of California, San Francisco
Active, not recruiting --> Completed Trial primary completion date: Jun 2016 --> Jan 2017
- Trial primary completion date, IO biomarker: Interferon Responses in Eczema Herpeticum (clinicaltrials.gov) - Oct 21, 2016
P=N/A, N=84, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Jun 2016 --> Jan 2017 Trial primary completion date: Aug 2016 --> Jan 2016
- Trial primary completion date: Registry for the Atopic Dermatitis Research Network (clinicaltrials.gov) - Oct 19, 2016
P=N/A, N=2600, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Aug 2016 --> Jan 2016 Trial primary completion date: Dec 2016 --> Feb 2020
- Trial completion, Enrollment change, Trial primary completion date, IO biomarker: Interferon Responses in Eczema Herpeticum (clinicaltrials.gov) - Oct 19, 2016
P=N/A, N=84, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Trial primary completion date: Dec 2016 --> Feb 2020 Recruiting --> Completed | N=120 --> 84 | Trial primary completion date: Dec 2016 --> Aug 2016
- Enrollment change, Trial initiation date, Trial withdrawal, Trial primary completion date, IO biomarker: The Effects of Polyunsaturated Fatty Acids (PUFA) on Allergic/Atopic Dermatitis (clinicaltrials.gov) - Sep 16, 2016
P=N/A, N=0, Withdrawn, Sponsor: Mead Johnson Nutrition
Recruiting --> Completed | N=120 --> 84 | Trial primary completion date: Dec 2016 --> Aug 2016 N=240 --> 0 | Initiation date: Apr 2015 --> Sep 2013 | Terminated --> Withdrawn | Trial primary completion date: Nov 2015 --> Nov 2014
- Trial completion: Bleach Bath Treatment of Adults With Atopic Dermatitis (clinicaltrials.gov) - Jul 12, 2016
P=N/A, N=46, Completed, Sponsor: University of Rochester
N=240 --> 0 | Initiation date: Apr 2015 --> Sep 2013 | Terminated --> Withdrawn | Trial primary completion date: Nov 2015 --> Nov 2014 Active, not recruiting --> Completed
- Enrollment change, Trial termination, Trial primary completion date: Vitamin D Supplementation in Polymorphic Light Eruption (clinicaltrials.gov) - Jun 14, 2016
P3, N=8, Terminated, Sponsor: Medical University of Graz
Active, not recruiting --> Completed N=36 --> 8 | Recruiting --> Terminated | Trial primary completion date: Oct 2015 --> May 2015; Difficulties in recruiting the planned number of patients